OTCMKTS:ADOCY - Adocia Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $19.00
  • Forecasted Upside: 72.41 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$11.02
▼ -0.01 (-0.09%)
1 month | 3 months | 12 months
Get New Adocia Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ADOCY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ADOCY

Average Price Target: $19.00
▲ +72.41% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Adocia in the last 3 months. The average price target is $19.00, with a high forecast of $19.00 and a low forecast of $19.00. The average price target represents a 72.41% upside from the last price of $11.02.

Buy

The current consensus among 2 polled investment analysts is to buy stock in Adocia.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/28/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/27/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/22/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/21/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/21/2020HC WainwrightLower Price TargetBuy$21.00 ➝ $19.00
9/17/2020HC WainwrightReiterated RatingBuy$21.00
7/22/2020Kepler Capital MarketsReiterated RatingBuy
10/15/2019HC WainwrightReiterated RatingBuy
1/27/2017SVB LeerinkDowngradeOutperform ➝ Market Perform
(Data available from 6/21/2016 forward)
Adocia logo
Adocia SA, a clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The company's proprietary BioChaperone technological platform is designed and developed to enhance the effectiveness and/or safety of therapeutic proteins. Its clinical product pipeline includes insulin formulations, such as BioChaperone Lispro U100 and U200, which are ultra-rapid formulations of insulin analog lispro; BioChaperone Combo, a combination of basal insulin glargine and rapid-acting insulin lispro; and BioChaperone Pramlintide Insulin, a prandial combination of human insulin with amylin pramlintide M1Pram. The company's clinical pipeline also includes BioChaperone Glucagon, which is an aqueous formulation of human glucagon for the treatment of hypoglycemia. Its preclinical pipeline includes BioChaperone LisPram), which is a combination of rapid human insulin analogues and Pramlintide; BioChaperone Glargine GLP1 that is a combination of insulin glargine with GLP-1 receptor agonists for the treatment of diabetes; and BioChaperone Glucagon GLP1, which is a combination of glucagon and a GLP-1 receptor agonist for the treatment of obesity. The company has a strategic alliance with Tonghua Dongbao Pharmaceutical Co., Ltd. to develop and commercialize BioChaperone Lispro and BioChaperone Combo in China and other Asian and Middle Eastern territories. Adocia SA was founded in 2005 and is headquartered in Lyon, France.
Read More

Today's Range

Now: $11.02
Low: $11.02
High: $11.02

50 Day Range

MA: $11.02
Low: $11.02
High: $11.03

52 Week Range

Now: $11.02
Low: $9.56
High: $13.22

Volume

208 shs

Average Volume

150 shs

Market Capitalization

$77.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97

Frequently Asked Questions

What sell-side analysts currently cover shares of Adocia?

The following Wall Street analysts have issued research reports on Adocia in the last year: HC Wainwright, Kepler Capital Markets, and Zacks Investment Research.
View the latest analyst ratings for ADOCY.

What is the current price target for Adocia?

1 Wall Street analysts have set twelve-month price targets for Adocia in the last year. Their average twelve-month price target is $19.00, suggesting a possible upside of 72.4%. HC Wainwright has the highest price target set, predicting ADOCY will reach $19.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $19.00 for Adocia in the next year.
View the latest price targets for ADOCY.

What is the current consensus analyst rating for Adocia?

Adocia currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ADOCY will outperform the market and that investors should add to their positions of Adocia.
View the latest ratings for ADOCY.

What other companies compete with Adocia?

How do I contact Adocia's investor relations team?

Adocia's physical mailing address is 115 avenue Lacassagne, Lyon I0, 69003. The company's listed phone number is 33-04-72-61-06-10 and its investor relations email address is [email protected]cap.fr. The official website for Adocia is www.adocia.com.